160 related articles for article (PubMed ID: 22114859)
1. Therapeutic potential of chemokine receptor antagonists for liver disease.
Sahin H; Berres ML; Wasmuth HE
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):503-13. PubMed ID: 22114859
[TBL] [Abstract][Full Text] [Related]
2. Chemokines as immune mediators of liver diseases related to the metabolic syndrome.
Berres ML; Nellen A; Wasmuth HE
Dig Dis; 2010; 28(1):192-6. PubMed ID: 20460910
[TBL] [Abstract][Full Text] [Related]
3. Chemokines in liver inflammation and fibrosis.
Wasmuth HE; Tacke F; Trautwein C
Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374
[TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines].
Wasmuth HE; Weiskirchen R
Z Gastroenterol; 2010 Jan; 48(1):38-45. PubMed ID: 20072995
[TBL] [Abstract][Full Text] [Related]
5. Chemokine-directed immune cell infiltration in acute and chronic liver disease.
Karlmark KR; Wasmuth HE; Trautwein C; Tacke F
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):233-42. PubMed ID: 19072358
[TBL] [Abstract][Full Text] [Related]
6. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics.
Wald O; Weiss ID; Galun E; Peled A
Cytokine; 2007 Jul; 39(1):50-62. PubMed ID: 17629707
[TBL] [Abstract][Full Text] [Related]
7. CCR1 antagonists for the treatment of autoimmune diseases.
Gladue RP; Zwillich SH; Clucas AT; Brown MF
Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis.
Shahrara S; Amin MA; Woods JM; Haines GK; Koch AE
Arthritis Rheum; 2003 Dec; 48(12):3568-83. PubMed ID: 14674010
[TBL] [Abstract][Full Text] [Related]
9. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
[TBL] [Abstract][Full Text] [Related]
10. CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis.
Holst PJ; Orskov C; Qvortrup K; Christensen JP; Thomsen AR
J Virol; 2007 Sep; 81(18):10101-12. PubMed ID: 17626099
[TBL] [Abstract][Full Text] [Related]
11. The clinical potential of chemokine receptor antagonists.
Ribeiro S; Horuk R
Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
[TBL] [Abstract][Full Text] [Related]
12. The chemokine family. Potential therapeutic targets from allergy to HIV infection.
Proudfoot AE
Eur J Dermatol; 1998; 8(3):147-57. PubMed ID: 9649701
[TBL] [Abstract][Full Text] [Related]
13. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.
Shields PL; Morland CM; Salmon M; Qin S; Hubscher SG; Adams DH
J Immunol; 1999 Dec; 163(11):6236-43. PubMed ID: 10570316
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
Elsner J; Escher SE; Forssmann U
Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
[TBL] [Abstract][Full Text] [Related]
16. Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection.
Thomas LH; Friedland JS; Sharland M
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):415-25. PubMed ID: 17547506
[TBL] [Abstract][Full Text] [Related]
17. Chemokine blockers--therapeutics in the making?
Wells TN; Power CA; Shaw JP; Proudfoot AE
Trends Pharmacol Sci; 2006 Jan; 27(1):41-7. PubMed ID: 16310864
[TBL] [Abstract][Full Text] [Related]
18. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5.
Pakianathan DR; Kuta EG; Artis DR; Skelton NJ; Hébert CA
Biochemistry; 1997 Aug; 36(32):9642-8. PubMed ID: 9289016
[TBL] [Abstract][Full Text] [Related]
19. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
Szczuciński A; Losy J
Acta Neurol Scand; 2007 Mar; 115(3):137-46. PubMed ID: 17295707
[TBL] [Abstract][Full Text] [Related]
20. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
Parody TR; Stone MJ
Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
